abstract |
The present invention relates to substituted ring fused azines and methods of using said compounds in treating cancer. More particularly, the invention relates to the preparation of 4-alkyl-2- (heterocyclic) -azines and their use as anticancer agents or drugs for cancer treatment. The compounds of the present invention exhibit advantageous in vivo and in vitro activity against selected cancers. |